PetMed Express, Inc. (NASDAQ: PETS) reported Q2 EPS of $0.19, $0.02 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $57.6 million versus the consensus estimate of $61.22 million.

For earnings history and earnings-related data on PetMed Express, Inc. (PETS) click here.